Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Gershman, Mark D. ; Sotir, Mark J.
• Description:
  Sanofi Pasteur, the manufacturer of the only yellow fever vaccine (YF-VAX) licensed in the United States, has announced that their stock of YF-VAX is totally depleted as of July 24, 2017. YF-VAX for civilian use will be unavailable for ordering from Sanofi Pasteur until mid-2018, when their new manufacturing facility is expected to be completed. However, YF-VAX might be available at some clinics for several months, until remaining supplies at those sites are exhausted. In anticipation of this temporary total depletion, in 2016, Sanofi Pasteur submitted an expanded access investigational new drug application to the Food and Drug Administration to allow for importation and use of Stamaril. The Food and Drug Administration accepted Sanofi Pasteur's application in October 2016.
• Subjects:
  Drugs, Investigational Full Report Humans Licensure Travel Yellow Fever Yellow Fever Vaccine
• Source:
  MMWR Morbidity Mortal Weekly Rep. 66(29):780.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm6629a4
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  28749924
• Pubmed Central ID:
  PMC5657809
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  1 pdf page
• Volume:
  66
• Issue:
  29
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:dd52c95576d705b5bf2778d0296936f89e88d89d7c0aead9753c0c75c43700df52d30fa38d9e256fb92a0f79124be7549b8d959aa03ea01f78e6fb5b610fb6df
• Download URL:
  https://stacks.cdc.gov/view/cdc/54563/cdc_54563_DS1.pdf
• File Type:
  [PDF - 63.92 KB ]